Citations

Mayo Clinic

Clear

55 citation(s) found for "Yamaguchi, Yu".

Effects of transdermal nicotine treatment on structure and function of coronary artery bypass grafts
Yamaguchi, Hiroki , Hurt, R. Douglas , Fitzpatrick, Lorraine A. , Moyer, Thomas P. , Rowland, C, Miller, Virginia M. , Clouse, William Darrin , Phillips, Michael , Schaff, Hartzell V.

Journal of Applied Physiology | December 23, 2017 | Volume: 89 | Issue: 3 | Pages: 1213-1223

10.1152/jappl.2000.89.3.1213 | PMID 10956371 Get It

Smoking is a major risk factor for failure of coronary artery bypass grafts (CABG). Experiments were designed to determine effects of transdermal nicotine, independent of smoking, on structure and function of CABG. Saphenous veins were placed as CABG in untreated dogs (control) or in dogs treated with transdermal nicotine (one 11-mg or two 22-mg patches/day) for 5 wk. Serum nicotine and plasma nitric oxide were measured. Grafts were removed and prepared for organ chamber studies and histology. Serum nicotine averaged 12.1 and 118.7 ng/ml in the 11 mg/day and 44 mg/day groups, respectively. Plasma nitric oxide was higher in dogs treated with 11 mg/day doses compared with controls. In organ chamber studies, endothelium-dependent relaxations to thrombin and A-23187 and endothelium-independent relaxations to nitric oxide were greatest in grafts from dogs treated with 11 mg/day doses. Intimal thickness of the grafts were similar among groups. However, staining for bone sialoprotein was increased in the media of grafts from the 11 mg/day treatment group. These data suggest that transdermal nicotine in doses comparable and double to those used for conventional smoking cessation treatment in humans does not adversely affect early patency of canine CABG up to 4 wk postoperatively. Transdermal nicotine, however, may increase production of and response to nitric oxide in bypass grafts.
Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica
Schaller, K , Owens, Gregory P. , Cotleur, Anne C. , Kellner, Debra , Takeshita, Yukio , Obermeier, Birgit , Kryzer, Thomas J., Sano, Yasuteru , Kanda, Takashi , Lennon, Vanda A. , Ransohoff, Richard M. , Bennett, Jeffrey L. , Shimizu, Fumitaka , Schaller, Kristin L , Kellner, Debra , Obermeier, Birgit , Sano, Yasuteru , Kanda, Takashi , Ransohoff, Richard M , Bennett, Jeffrey L , Shimizu, Fumitaka , Cotleur, Anne C

Science Translational Medicine | October 12, 2017 | Volume: 9 | Issue: 397 | Pages: No page available

10.1126/scitranslmed.aai9111 | PMID 28679661 Get It

An autoantibody target on brain microvascular endothelial cells in patients with neuromyelitis optica may be exploited to manipulate blood-brain barrier permeability.
Exploratory analysis of left- versus right-sided colorectal carcinoma in RAISE: A randomized, double-blind, phase 3 trial of ramucirumab (RAM) + FOLFIRI versus placebo (PBO) + FOLFIRI.
Portnoy, David C. , Obermannová, Radka , Prausová, Jana, Cohn, Allen Lee, Yamazaki, Kentaro , Kim, Tae Won , Yamaguchi, Kensei , ́Connor, Juan Manuel O , Hsu, Yanzhi, Ferry, David, Nasroulah, Federico, Bodoky, Gyorgy , García‐Carbonero, Rocio , Ciuleanu, Tudor–Eliade , Alfonso, Pilar , Cutsem, Eric Van , Yoshino, Takayuki , Lonardi, Sara , Grothey, Axel , Tabernero, Josep

Journal of Clinical Oncology | March 21, 2017 | Volume: 35 | Issue: 4_suppl | Pages: 668-668

10.1200/jco.2017.35.4_suppl.668 Get It

668 Background: Ramucirumab is a human IgG1 monoclonal antibody antagonist of VEGFR-2. Overall survival (OS) and progression-free survival (PFS) in 2nd line FOLFIRI based treatment for metastatic colorectal cancer (mCRC) were improved with RAM therapy versus PBO in the RAISE trial. Recent work suggests mCRC primary tumor location is both prognostic and predictive; with improved OS and therapy-specific sensitivity observed in left (L)- vs right (R)-sided tumors. Given these findings, the RAISE trial data was subjected to post-hoc analysis to determine if sidedness influenced RAM efficacy. Methods: Primary tumor site was obtained. L-CRC was defined as the splenic flexure, descending and sigmoid colon, and rectum, while R-CRC included transverse, ascending colon and cecum. OS/PFS in L and R subgroups were analyzed via Kaplan-Meier method and unstratified log-rank test (treatments within subgroup), unstratified Cox proportional hazards model (estimate hazard ratio [HR] and 95% CI), and Wald test (treatment-by-subgroup interaction). Results: Tumor location was available for 1012/1072 (94%) patients, 699 L- and 313 R-CRC. Baseline characteristics were balanced between arms. RAM treatment enhanced L-CRC median OS by 2.5 mo (median 14.5 vs 12.0 mo) with a HR (95% CI) = 0.807 (0.675, 0.965), P = 0.019; compared to a 1.1 mo increase in median OS in R-CRC vs PBO (12.7 vs 11.6) with a HR (95% CI) = 0.971 (0.750, 1.258), P = 0.823; and, RAM enhanced L-CRC median PFS by 1.6 mo (6.0 vs 4.4 mo) and HR (95% CI) = 0.776 (0.664, 0.906), P = 0.001 compared to a 1.1 mo increase in median PFS R-CRC vs PBO (5.6 vs 4.5) with a HR (95% CI) = 0.855 (0.674, 1.084), P = 0.197. The treatment-by-subgroup interaction for both OS and PFS was not significant ( P = 0.276, 0.578, respectively). Conclusions: Despite L-CRC patients having longer OS/PFS and a seemingly stronger RAM treatment effect than R-CRC, the non-significant interaction test cannot verify sidedness as being predictive of RAM efficacy. The current study confirms ramucirumab benefits mCRC patients regardless primary tumor location. Clinical trial information: NCT01183780.
Effects of neuromyelitis optica–IgG at the blood–brain barrier in vitro
Takeshita, Yukio , Obermeier, Birgit , Cotleur, Anne C. , Spampinato, Simona Federica , Yamamoto, Erin , Sano, Yasuteru , Kryzer, Thomas J., Lennon, Vanda A. , Kanda, Takashi , Ransohoff, Richard M. , Spampinato, Simona F, Shimizu, Fumitaka , Cotleur, Anne C

Neurology Neuroimmunology & Neuroinflammation | December 19, 2016 | Volume: 4 | Issue: 1 | Pages: No page available

10.1212/nxi.0000000000000311 | PMID 28018943 Get It

Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer’s disease
Liu, Chia‐Chen , Zhao, Na , Cirrito, John R. , Kanekiyo, Takahisa , Bu, Guojun , Yamaguchi, Yu , Holtzman, David M. , Liu, Chia-Chen , Bu, Guojun , Zhao, Na

Science Translational Medicine | March 30, 2016 | Volume: 8 | Issue: 332 | Pages: No page available

10.1126/scitranslmed.aad3650 | PMID 27030596 Get It

Deleting neuronal heparan sulfates in a mouse model of Alzheimer’s disease results in faster Aβ clearance, reduced Aβ aggregation, and less amyloid pathology.
Tips for laparoscopic pancreaticoduodenectomy
Asbun, Horacio J. , Harada, Eijiro , Stauffer, John , A Stauffer, John

Journal of Hepato-Biliary-Pancreatic Sciences | March 22, 2016 | Volume: 23 | Issue: 3 | Pages: No page available

10.1002/jhbp.325 | PMID 27003875 Get It

Laparoscopic pancreaticoduodenectomy (LPD) is one of the most complex procedures performed in laparoscopic abdominal surgery, and its practice is still limited to only a few selected centers. Surgeons need to be proficient in advanced laparoscopic techniques and have a thorough understanding of the advantages and disadvantages inherent to the laparoscopic approach. LPD can be divided into the following steps: division of the omentum and colon mobilization; division of the proximal bowel and gastroduodenal artery, and transection of the common bile duct; making a retropancreatic window; dissection of ligament of Treitz and division of the distal bowel; dissection of the uncinate process and superior mesenteric vessels; and reconstruction. In this article, we describe our conventional technique for LPD.
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Galon, Jérôme , Mlecnik, Bernhard , Bindea, Gabriela , Berger, Anne, Lagorce, Christine, Lugli, Alessandro , Zlobec, Inti , Hartmann, Arndt , Bifulco, Carlo , Nagtegaal, Irıs D. , Masucci, Giuseppe , Botti, Gerardo , Tatangelo, Fabiana , Delrio, Paolo , Maio, Michele , Laghi, Luigi , Grizzi, Fabio , Asslaber, Martin, D’Arrigo, Corrado, Vidal‐Vanaclocha, Fernando, Závadová, Eva, Ohashi, Pamela S. , Hafezi‐Bakhtiari, Sara, Wouters, Bradly G. , Roehrl, Michael H. A. , Nguyen, Linh N, Kawakami, Yutaka , Hazama, Shoichi , Okuno, Kiyotaka, Ogino, Shuji , Gibbs, Peter , Waring, Paul , Sato, Noriyuki , Itoh, Kyogo, Patel, Prabhudas S. , Shukla, Shilin N., Wang, Yili , Kopetz, Scott , Scripcariu, Viorel , Ascierto, Paolo A. , Marincola, Francesco M. , Fox, Bernard A. , Pagès, Franck , Angell, Helen K. , Palmqvist, Richard , Chouchane, Lotfi , Ogino, Shuji , Torigoe, Toshihiko , Sinicrope, Frank A. , Galon, Jerome , Kopetz, Scott , Nagtegaal, Iris D

The Journal of Pathology | October 11, 2013 | Volume: 232 | Issue: 2 | Pages: 199-209

10.1002/path.4287 | PMID 24122236 Get It

Abstract The American Joint Committee on Cancer/Union Internationale Contre le Cancer ( AJCC / UICC ) TNM staging system provides the most reliable guidelines for the routine prognostication and treatment of colorectal carcinoma. This traditional tumour staging summarizes data on tumour burden (T), the presence of cancer cells in draining and regional lymph nodes (N) and evidence for distant metastases (M). However, it is now recognized that the clinical outcome can vary significantly among patients within the same stage. The current classification provides limited prognostic information and does not predict response to therapy. Multiple ways to classify cancer and to distinguish different subtypes of colorectal cancer have been proposed, including morphology, cell origin, molecular pathways, mutation status and gene expression‐based stratification. These parameters rely on tumour‐cell characteristics. Extensive literature has investigated the host immune response against cancer and demonstrated the prognostic impact of the in situ immune cell infiltrate in tumours. A methodology named ‘Immunoscore’ has been defined to quantify the in situ immune infiltrate. In colorectal cancer, the Immunoscore may add to the significance of the current AJCC / UICC TNM classification, since it has been demonstrated to be a prognostic factor superior to the AJCC / UICC TNM classification. An international consortium has been initiated to validate and promote the Immunoscore in routine clinical settings. The results of this international consortium may result in the implementation of the Immunoscore as a new component for the classification of cancer, designated TNM ‐I ( TNM ‐Immune). © 2013 The Authors. Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
Hyperemia and ischemia in experimental cerebral infarction
Yamaguchi, Takenori , Waltz, Arthur G., Okazaki, Haruo

Neurology | May 13, 2012 | Volume: 21 | Issue: 6 | Pages: 565-565

10.1212/wnl.21.6.565 | PMID 5105412 Get It

Effects of Acetazolamide on Cerebral Ischemia and Infarction After Experimental Occlusion of Middle Cerebral Artery
Régli, F, Yamaguchi, Takenori , Waltz, Arthur G.

Stroke | June 17, 2011 | Volume: 2 | Issue: 5 | Pages: 456-460

10.1161/01.str.2.5.456 | PMID 5000028 Get It

Acetazolamide was given to five of ten cats for 48 to 54 hours after extradural occlusion of a middle cerebral artery (MCA). At seven to eight days later, measurements of regional cerebral blood flow (CBF) and estimates of the sizes of the ischemic and infarcted areas of the brains were made. Neurological deficits were more severe and the ischemic and infarcted regions were larger in the cats given acetazolamide. Cerebral edema (brain swelling) was present and reactive hyperemia was common in the treated cats, even one week after MCA occlusion. The hypercapnia and decreases of pH of nonischemic brain tissue that are caused by acetazolamide are harmful for ischemic brain tissue, presumably because of vasodilatation in nonischemic brain tissue with resultant increases of intracranial pressure and decreases of CBF of ischemic regions.
Effects of Inhalation of Oxygen on Blood Flow and Microvasculature of Ischemic and Nonischemic Cerebral Cortex
Régli, F, Yamaguchi, Takenori , Waltz, Arthur G.

Stroke | June 17, 2011 | Volume: 1 | Issue: 5 | Pages: 314-319

10.1161/01.str.1.5.314 | PMID 5522929 Get It

The right middle cerebral artery was occluded in cats, and Pa o o2 was increased by increasing the amount of oxygen inhaled by the animals at atmospheric pressure. Cortical blood flow (CBF) was measured with Krypton-85, and observations and photographs of the superficial cortical microvasculature were made bilaterally. In two of five animals, increasing the Pa o o2 caused constriction of surface arterioles of the nonischemic hemispheres, with an associated decrease of CBF; in the three other animals, there were no circulatory responses to the increased Pa o o2 . In seven animals, increasing the Pa o o2 had no apparent effect on CBF or arteriolar caliber of the ischemic cerebral hemispheres. In four animals, at Pa o o2 greater than 400 torr, reactivity to increases of Pa CO CO2 was preserved in nonischemic cortex but impaired in ischemic cortex. Reddening of venous blood of the microvasculature of ischemic cerebral cortex occurred when Pa o o2 was increased, indicating that more oxygen was made available to the ischemic cerebral tissue. However, no beneficial effects could be demonstrated on the changes in the microvasculature produced by ischemia.